Coursera (COUR) 10-Q 2 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Oct. 26, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-40275
Entity Registrant Name	COURSERA, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	45-3560292
Entity Address, Address Line One	381 E. Evelyn Ave.
Entity Address, City or Town	Mountain View
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94041
City Area Code	650
Local Phone Number	963-9884
Title of 12(b) Security	Common Stock, $0.00001 par value per share
Trading Symbol	COUR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		152,547,664
Entity Central Index Key	0001651562
Document Fiscal Year Focus	2023
Amendment Flag	false
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 507,157	$ 320,817
Marketable securities	213,996	459,654
Accounts receivable, net of allowance for credit losses of $196 and $495 as of September 30, 2023 and December 31, 2022	62,104	53,734
Deferred costs, net	26,428	24,147
Prepaid expenses and other current assets	19,450	17,636
Total current assets	829,135	875,988
Property, equipment, and software, net	29,699	27,096
Operating lease right-of-use assets	5,975	9,605
Intangible assets, net	10,690	8,553
Other assets	38,846	26,355
Total assets	914,345	947,597
Current liabilities:
Educator partners payable	98,063	66,375
Other accounts payable and accrued expenses	25,108	23,342
Accrued compensation and benefits	18,912	21,163
Operating lease liabilities, current	7,376	8,658
Deferred revenue, current	138,687	115,701
Other current liabilities	7,497	7,202
Total current liabilities	295,643	242,441
Operating lease liabilities, non-current	1,093	5,791
Deferred revenue, non-current	2,540	3,076
Other liabilities	1,668	1,714
Total liabilities	300,944	253,022
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.00001 par value—10,000,000 shares authorized and no shares issued and outstanding as of September 30, 2023 and December 31, 2022	0	0
Common stock, $0.00001 par value—300,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 159,836,721 shares issued and 152,258,980 shares outstanding as of September 30, 2023, and 150,683,607 shares issued and 147,935,669 shares outstanding as of December 31, 2022	2	1
Additional paid-in capital	1,437,092	1,364,116
Treasury stock—at cost, 7,577,741 and 2,747,938 shares as of September 30, 2023 and December 31, 2022	(63,154)	(4,701)
Accumulated other comprehensive loss	(219)	(718)
Accumulated deficit	(760,320)	(664,123)
Total stockholders’ equity	613,401	694,575
Total liabilities and stockholders’ equity	$ 914,345	$ 947,597

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 196	$ 495
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares issued (in shares)	159,836,721	150,683,607
Common stock, shares outstanding (in shares)	152,258,980	147,935,669
Treasury stock, shares (in shares)	7,577,741	2,747,938

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue	$ 165,540,000	$ 136,389,000	$ 466,884,000	$ 381,576,000
Cost of revenue	82,267,000	48,821,000	226,442,000	137,972,000
Gross profit	83,273,000	87,568,000	240,442,000	243,604,000
Operating expenses:
Research and development	37,616,000	39,415,000	122,711,000	122,299,000
Sales and marketing	59,792,000	58,504,000	164,665,000	165,757,000
General and administrative	25,449,000	25,998,000	75,909,000	76,902,000
Restructuring related charges	0	0	(5,806,000)	0
Total operating expenses	122,857,000	123,917,000	357,479,000	364,958,000
Loss from operations	(39,584,000)	(36,349,000)	(117,037,000)	(121,354,000)
Interest income	8,857,000	2,301,000	25,134,000	3,473,000
Other expense, net	(325,000)	(976,000)	(231,000)	(2,574,000)
Loss before income taxes	(31,052,000)	(35,024,000)	(92,134,000)	(120,455,000)
Income tax expense	1,038,000	1,014,000	4,063,000	3,185,000
Net loss	$ (32,090,000)	$ (36,038,000)	$ (96,197,000)	$ (123,640,000)
Net loss per share - basic (in dollars per share)	$ (0.21)	$ (0.25)	$ (0.64)	$ (0.85)
Net loss per share - diluted (in dollars per share)	$ (0.21)	$ (0.25)	$ (0.64)	$ (0.85)
Weighted average shares used in computing net loss per share - basic (in shares)	150,853,611	146,020,571	150,036,927	144,619,748
Weighted average shares used in computing net loss per share - diluted (in shares)	150,853,611	146,020,571	150,036,927	144,619,748

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (32,090)	$ (36,038)	$ (96,197)	$ (123,640)
Change in unrealized gain (loss) on marketable securities, net of tax	401	839	499	(1,227)
Comprehensive loss	$ (31,689)	$ (35,199)	$ (95,698)	$ (124,867)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		144,653,979
Beginning balance at Dec. 31, 2021	$ 741,513	$ 1	$ 1,235,231	$ (4,701)	$ (252)	$ (488,766)
Treasury stock, beginning balance (in shares) at Dec. 31, 2021				(2,747,938)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		3,509,007
Issuance of common stock upon exercise of options	14,198		14,198
Vesting of restricted stock units (in shares)		1,094,522
Tax withholding on vesting of restricted stock units (in shares)		(410,918)
Tax withholding on vesting of restricted stock units	(6,798)		(6,798)
Issuance of restricted stock awards (in shares)		5,518
Issuance of common stock related to employee stock purchase plan (in shares)		353,828
Issuance of common stock related to employee stock purchase plan	4,596		4,596
Stock-based compensation expense	80,339		80,339
Change in unrealized gain (loss) on marketable securities	(1,227)				(1,227)
Net loss	(123,640)					(123,640)
Ending balance (in shares) at Sep. 30, 2022		149,205,936
Ending balance at Sep. 30, 2022	708,981	$ 1	1,327,566	$ (4,701)	(1,479)	(612,406)
Treasury stock, ending balance (in shares) at Sep. 30, 2022				(2,747,938)
Beginning balance (in shares) at Jun. 30, 2022		148,332,771
Beginning balance at Jun. 30, 2022	715,787	$ 1	1,299,173	$ (4,701)	(2,318)	(576,368)
Treasury stock, beginning balance (in shares) at Jun. 30, 2022				(2,747,938)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		635,319
Issuance of common stock upon exercise of options	2,713		2,713
Vesting of restricted stock units (in shares)		372,157
Tax withholding on vesting of restricted stock units (in shares)		(139,829)
Tax withholding on vesting of restricted stock units	(1,946)		(1,946)
Issuance of restricted stock awards (in shares)		5,518
Stock-based compensation expense	27,626		27,626
Change in unrealized gain (loss) on marketable securities	839				839
Net loss	(36,038)					(36,038)
Ending balance (in shares) at Sep. 30, 2022		149,205,936
Ending balance at Sep. 30, 2022	$ 708,981	$ 1	1,327,566	$ (4,701)	(1,479)	(612,406)
Treasury stock, ending balance (in shares) at Sep. 30, 2022				(2,747,938)
Beginning balance (in shares) at Dec. 31, 2022	147,935,669	150,683,607
Beginning balance at Dec. 31, 2022	$ 694,575	$ 1	1,364,116	$ (4,701)	(718)	(664,123)
Treasury stock, beginning balance (in shares) at Dec. 31, 2022	(2,747,938)			(2,747,938)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		4,926,957
Issuance of common stock upon exercise of options	$ 20,902	$ 1	20,901
Vesting of restricted stock units (in shares)		6,558,634
Tax withholding on vesting of restricted stock units (in shares)		(2,697,932)
Tax withholding on vesting of restricted stock units	(38,682)		(38,682)
Repurchases of common stock (in shares)				(4,829,803)
Repurchases of common stock	(58,453)			$ (58,453)
Issuance of restricted stock awards (in shares)		13,516
Issuance of common stock related to employee stock purchase plan (in shares)		351,939
Issuance of common stock related to employee stock purchase plan	3,530		3,530
Stock-based compensation expense	87,227		87,227
Change in unrealized gain (loss) on marketable securities	499				499
Net loss	$ (96,197)					(96,197)
Ending balance (in shares) at Sep. 30, 2023	152,258,980	159,836,721
Ending balance at Sep. 30, 2023	$ 613,401	$ 2	1,437,092	$ (63,154)	(219)	(760,320)
Treasury stock, ending balance (in shares) at Sep. 30, 2023	(7,577,741)			(7,577,741)
Beginning balance (in shares) at Jun. 30, 2023		156,904,092
Beginning balance at Jun. 30, 2023	$ 626,481	$ 2	1,414,559	$ (59,230)	(620)	(728,230)
Treasury stock, beginning balance (in shares) at Jun. 30, 2023				(7,268,231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		1,667,145
Issuance of common stock upon exercise of options	6,788		6,788
Vesting of restricted stock units (in shares)		2,144,526
Tax withholding on vesting of restricted stock units (in shares)		(885,753)
Tax withholding on vesting of restricted stock units	(13,827)		(13,827)
Repurchases of common stock (in shares)				(309,510)
Repurchases of common stock	(3,924)			$ (3,924)
Issuance of restricted stock awards (in shares)		6,711
Stock-based compensation expense	29,572		29,572
Change in unrealized gain (loss) on marketable securities	401				401
Net loss	$ (32,090)					(32,090)
Ending balance (in shares) at Sep. 30, 2023	152,258,980	159,836,721
Ending balance at Sep. 30, 2023	$ 613,401	$ 2	$ 1,437,092	$ (63,154)	$ (219)	$ (760,320)
Treasury stock, ending balance (in shares) at Sep. 30, 2023	(7,577,741)			(7,577,741)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (96,197)	$ (123,640)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	16,502	13,507
Stock-based compensation expense	81,903	75,853
(Amortization) accretion of marketable securities	(12,301)	1,046
Impairment of long-lived assets	2,844	6,124
Other	693	1,070
Changes in operating assets and liabilities:
Accounts receivable, net	(9,032)	(21,059)
Prepaid expenses and other assets	(17,008)	(19,454)
Operating lease right-of-use assets	3,631	3,655
Accounts payable and accrued expenses	32,568	18,232
Accrued compensation and other liabilities	(2,003)	(4,498)
Operating lease liabilities	(5,980)	(4,788)
Deferred revenue	22,451	21,343
Net cash provided by (used in) operating activities	18,071	(32,609)
Cash flows from investing activities:
Purchases of marketable securities	(121,756)	(287,639)
Proceeds from maturities of marketable securities	380,000	165,000
Purchases of property, equipment, and software	(1,026)	(1,386)
Capitalized internal-use software costs	(11,463)	(10,082)
Purchase of investment in private company	(1,701)	0
Purchases of content assets	(3,377)	(1,295)
Net cash provided by (used in) investing activities	240,677	(135,402)
Cash flows from financing activities:
Proceeds from exercise of stock options	20,901	14,641
Proceeds from employee stock purchase plan	3,530	4,596
Payments for repurchases of common stock	(58,453)	0
Payment of deferred offering costs	0	(295)
Payments for tax withholding on vesting of restricted stock units	(38,682)	(6,793)
Net cash (used in) provided by financing activities	(72,704)	12,149
Net increase (decrease) in cash, cash equivalents, and restricted cash	186,044	(155,862)
Cash, cash equivalents, and restricted cash—Beginning of period	322,878	582,719
Cash, cash equivalents, and restricted cash—End of period	508,922	426,857
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	507,157	424,796
Restricted cash, non-current	1,765	2,061
Total cash, cash equivalents, and restricted cash	508,922	426,857
Supplemental disclosure of cash flow information:
Cash paid for income taxes, net of refunds	3,809	2,622
Supplemental disclosure of noncash investing and financing activities:
Stock-based compensation capitalized as internal-use software costs	5,324	4,486
Unpaid purchases of content assets	$ 1,361	$ 0

Basis of Presentation and Descr

Basis of Presentation and Description of Business	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Description of Business	BASIS OF PRESENTATION AND DESCRIPTION OF BUSINESS Basis of Presentation The accompanying Condensed Consolidated Financial Statements (Unaudited) of Coursera, Inc., a Delaware public benefit corporation, and its subsidiaries (“Coursera,” the “Company,” “we,” “us,” or “our”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and following the requirements of the Securities and Exchange Commission (“SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP can be condensed or omitted. These Condensed Consolidated Financial Statements (Unaudited) have been prepared on the same basis as our annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for a fair statement of our financial information. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other interim period or for any other future year. The balance sheet as of December 31, 2022 has been derived from the Consolidated Financial Statements at that date but does not include all information required by GAAP for annual consolidated financial statements. These Condensed Consolidated Financial Statements (Unaudited) should be read in conjunction with the Consolidated Financial Statements contained in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 23, 2023 (“Form 10-K”). Description of Business

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Significant Accounting Policies	SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The Condensed Consolidated Financial Statements (Unaudited) include the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Reporting Segments We conduct our operations through three reporting segments: Consumer, Enterprise, and Degrees. Refer to Note 13 for additional information. Use of Estimates The preparation of the Condensed Consolidated Financial Statements (Unaudited) in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and related disclosures as of the date of the Condensed Consolidated Financial Statements (Unaudited), as well as the reported amounts of revenue and expenses during the reporting period. We base our estimates on historical experience, current conditions, and various other factors that we believe to be reasonable under the circumstances. Significant items subject to such estimates, judgements, and assumptions include, but are not limited to, those related to the determination of principal versus agent and variable consideration in our revenue contracts; stock-based compensation expense; period of benefit for capitalized commissions; internal-use software costs; useful lives of long-lived assets; the carrying value of operating lease right-of-use assets; the valuation of intangible assets and income tax expense, including the valuation of deferred tax assets and liabilities, among others. Actual results could differ from those estimates, and any such differences could be material to our Condensed Consolidated Financial Statements (Unaudited). Summary of Significant Accounting Policies There have been no significant changes to our significant accounting policies, other than the update described below, as of and for the three and nine months ended September 30, 2023 as compared to the significant accounting policies described in our Form 10-K. Contract Acquisition and Fulfillment Costs Deferred Commissions Customer acquisition costs are primarily related to sales commissions and related payroll taxes earned by our Enterprise sales force, which are incremental costs we incur to obtain a contract. Sales commissions and related payroll costs earned by our Enterprise sales force, which are incremental costs we incur to obtain a contract, are deferred and then amortized on a straight-line basis over the expected period of benefit. On an annual basis, we assess the expected period of benefit by taking into consideration the length of terms in Enterprise customer contracts, the life of the technology, and other factors. Based on our most recent assessment, we determined that the expected period of benefit for incremental costs of our Enterprise customer contracts should be increased from three years to four years. This change in accounting estimate was eff ective January 1, 2023 and is accounted for prospectively in our Condensed Consolidated Financial Statements (Unaudited). For the three and nine months ended September 30, 2023, the change in the expected period of benefit resulted in a benefit to sales and marketing expenses o f $802 and $2,956 . Sal es commissions and related payroll taxes paid for Enterprise contract renewals continue to be amortized over the renewal term, which is generally two years. Deferred commissions and related payroll taxes are recorded within deferred costs or other assets in the consolidated balance sheets, depending on the timing of the related amortization. They are amortized to sales and marketing in the consolidated statements of operations. Concentration of Credit Risk Financial instruments that potentially subject us to concentration of credit risk consist of cash, cash equivalents, and marketable securities. We only invest in high-credit-quality instruments and maintain our cash equivalents and marketable securities in fixed-income securities. We place our cash primarily with domestic financial institutions that are federally insured within statutory limits.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	REVENUE RECOGNITION Contract Balances Contract assets and liabilities were as follows: September 30, 2023 December 31, 2022 January 1, 2022 Contract assets: Billed accounts receivable, net of allowance for credit losses $ 55,647 $ 45,337 $ 22,286 Unbilled accounts receivable 6,457 8,397 12,110 Total contract assets $ 62,104 $ 53,734 $ 34,396 Contract liabilities: Deferred revenue $ 141,227 $ 118,777 $ 98,488 Total contract liabilities $ 141,227 $ 118,777 $ 98,488 Revenue recognized during the nine months ended September 30, 2023 and 2022 that was included in the corresponding deferred revenue balance at the beginning of each year was $107,448 and $85,754. Remaining Performance Obligations Remaining performance obligations represent future revenue that is under non-cancelable contracts but has not yet been recognized. As of September 30, 2023, we had remaining performance obligations of $318,806 and expect to recognize approximately 66% of this balance as revenue over the next 12 months and the remainder thereafter. Costs to Obtain and Fulfill Contracts The following table presents our capitalization and amortization of commissions and related payroll tax expenditures: Three Months Ended September 30, Nine Months Ended September 30, Commissions and related payroll tax expenditures: 2023 2022 2023 2022 Capitalization $ 3,856 $ 4,365 $ 11,554 $ 11,464 Amortization $ 3,189 $ 3,304 $ 8,803 $ 9,051 Deferred commissions and related payroll tax expenditures included in deferred costs, net and in other assets were as follows: September 30, 2023 December 31, 2022 Deferred costs, net $ 12,219 $ 13,300 Other assets $ 14,258 $ 10,426 During the three and nine months ended September 30, 2022, we recognized impairment losses of $1,029 and $2,915, within general and administrative expenses in the Condensed Consolidated Statements of Operations (Unaudited), on deferred partner fees that we do not expect to recover from Russian educator partners whose content we removed from our platform. During the three and nine months ended September 30, 2023, we recognized impairment losses of $1,473 and $2,008, within sales and marketing expenses in the Condensed Consolidated Statements of Operations (Unaudited), on content development grants that we do not expect to recover related to our Degrees programs.

Investments

Investments	9 Months Ended
	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Investments	INVESTMENTS Investments Measured at Fair Value on a Recurring Basis The following table summarizes our investments measured at fair value on a recurring basis by balance sheet classification and investment type: September 30, 2023 December 31, 2022 Amortized Gross Gross Fair Amortized Gross Gross Fair Cash equivalents—money market funds $ 204,011 $ — $ — $ 204,011 $ 304,750 $ — $ — $ 304,750 Cash equivalents—U.S. Treasury securities 271,695 40 — 271,735 — — — — Total cash equivalents 475,706 40 — 475,746 304,750 — — 304,750 Marketable securities—U.S. Treasury securities 214,255 1 (260) 213,996 460,372 26 (744) 459,654 Total $ 689,961 $ 41 $ (260) $ 689,742 $ 765,122 $ 26 $ (744) $ 764,404 Gross realized gains and losses related to our marketable securities were not material for the three and nine months ended September 30, 2023 and 2022. The following table presents the cost basis and fair value of our available-for-sale (“AFS”) marketable securities by contractual maturity date: September 30, 2023 December 31, 2022 Amortized Fair Amortized Fair Due in one year or less $ 214,255 $ 213,996 $ 460,372 $ 459,654 Investments in an unrealized loss position consisted of the following: September 30, 2023 December 31, 2022 Fair Gross Fair Gross U.S. Treasury securities $ 204,001 $ (260) $ 356,767 $ (744) As of September 30, 2023 and December 31, 2022, our AFS marketable securities were comprised of U.S. Treasury securities, which are backed by the full faith and credit of the U.S. government. As a result, there were no credit or non-credit impairment charges recorded during the three and nine months ended September 30, 2023 and 2022. Investments Measured at Fair Value on a Nonrecurring Basis In August 2023, we acquired an approximate 7% ownership interest in a privately held company, which is measured and accounted for using the fair value measurement alternative basis. This investment is classified within other assets on the Condensed Consolidated Balance Sheets (Unaudited). The carrying value of the investment was $1,701 as of September 30, 2023. Our existing equity investments are remeasured at fair value on a nonrecurring basis when an identifiable event or change in circumstance may have a significant adverse impact on its fair value. No such events or changes occurred during the three and nine months ended September 30, 2023 and 2022.

Consolidated Balance Sheet Comp

Consolidated Balance Sheet Components	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Consolidated Balance Sheet Components	CONSOLIDATED BALANCE SHEET COMPONENTS Restricted Cash Restricted cash, current is included in prepaid expenses and other current assets, and restricted cash, non-current is included in other assets, both in the Condensed Consolidated Balance Sheets (Unaudited). Property, Equipment, and Software, Net Property, equipment, and software, net consisted of the following: September 30, 2023 December 31, 2022 Internal-use software and website development $ 68,746 $ 53,215 Computer equipment and purchased software 5,310 4,662 Leasehold improvements 6,923 6,567 Furniture and fixtures 2,759 2,714 Total property, equipment, and software 83,738 67,158 Less accumulated depreciation and amortization (54,039) (40,062) Property, equipment, and software, net $ 29,699 $ 27,096 The following table presents depreciation and amortization expense related to property, equipment, and software as well as the portion of amortization expense related to internal-use software and website development that is recorded within cost of revenue in the Condensed Consolidated Statements of Operations (Unaudited): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Depreciation and amortization expense $ 4,924 $ 4,223 $ 14,396 $ 11,541 Amortization expense for internal-use software and website development $ 4,320 $ 3,545 $ 12,584 $ 9,415 Intangible Assets, Net Intangible assets, net consisted of the following: September 30, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Content assets $ 11,064 $ (3,025) $ 8,039 $ 6,821 $ (1,971) $ 4,850 Developed technology 8,446 (5,795) 2,651 8,446 (4,743) 3,703 Assembled workforce — — — 181 (181) — Intangible assets $ 19,510 $ (8,820) $ 10,690 $ 15,448 $ (6,895) $ 8,553 Capitalization of content assets and amortization expense for intangible assets was as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Capitalization of content assets $ 2,247 $ 484 $ 4,243 $ 861 Amortization expense for intangible assets $ 736 $ 664 $ 2,106 $ 1,967 As of September 30, 2023, future expected amortization expense for intangible assets was as follows: Remainder of 2023 $ 877 2024 3,801 2025 3,214 2026 1,306 2027 875 Thereafter 617 Total $ 10,690

Leases

Leases	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Leases	LEASES We have entered into various non-cancelable office space operating leases with lease periods expiring through April 2025. These leases do not contain residual value guarantees, covenants, or other restrictions. In May 2022, we entered into a sublease agreement pursuant to which we subleased a part of our existing office space in Mountain View, California. We classified the sublease as an operating lease. The term of the sublease commenced on June 1, 2022 and terminates on October 31, 2024. Sublease income from this agreement was $680 and $2,040 for the three and nine months ended September 30, 2023 and was $680 and $907 for the three and nine months ended September 30, 2022. During the three and nine months ended September 30, 2022, we recognized an impairment loss of $0 and $2,304 related to our operating lease right-of-use asset and $0 and $904 related to property and equipment, which were allocated within operating expenses in the Condensed Consolidated Statements of Operations (Unaudited), consistent with the allocation approach used for operating lease costs. No such impairment loss was recognized during the three and nine months ended September 30, 2023.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES Income tax expense or benefit for interim periods is determined using an estimate of our annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, we update the estimate of the annual effective tax rate, and if the estimated tax rate changes, we record a cumulative adjustment. Our effective tax rate for the three months ended September 30, 2023 and 2022 was (3.3%) and (2.9%). For the nine months ended September 30, 2023 and 2022, our effective tax rate was (4.4%) and (2.6%). The difference between the effective tax rate and the U.S. federal statutory rate is primarily due to a valuation allowance for our federal and state net deferred tax assets, income taxes on foreign operations, U.S. state income taxes, and stock-based compensation expense.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	NET LOSS PER SHARE The following table presents the calculation of basic and diluted net loss per share: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss $ (32,090) $ (36,038) $ (96,197) $ (123,640) Denominator: Weighted-average shares used in computing net loss per share—basic and diluted 150,853,611 146,020,571 150,036,927 144,619,748 Net loss per share—basic and diluted $ (0.21) $ (0.25) $ (0.64) $ (0.85) The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been anti-dilutive: Three and Nine Months Ended September 30, 2023 2022 Common stock options 12,962,760 18,815,019 Restricted stock units (“RSUs”) 20,125,138 19,522,108 Shares subject to repurchase 6,711 5,518 ESPP stock purchase rights (“ESPP Rights”) 335,440 287,284 Total 33,430,049 38,629,929

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Purchase Obligations Purchase obligations relate mainly to a third-party cloud infrastructure agreement, subscription arrangements, and service agreements used to facilitate our operations. As of September 30, 2023, we had approximately $24,934 of future minimum payments under our non-cancelable purchase obligations with a remaining term in excess of one year, which are expected to be paid through 2026. Litigation We evaluate uncertainties associated with litigation and record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that a liability has been incurred at the date of the financial statements and (ii) the loss or range of loss can be reasonably estimated. If we determine that a loss is possible and a range of the loss can be reasonably estimated, we disclose the range of the possible loss in the notes to the Condensed Consolidated Financial Statements (Unaudited). We evaluate, on a quarterly basis, developments in our legal matters that could affect the amount of liability that has been previously accrued, if any, and the matters and related ranges of possible losses in order to make adjustments and changes to our disclosures as appropriate. Significant judgment is required to determine both likelihood of there being, and the estimated amount of, possible losses related to such matters. Until the final resolution of such matters, there may be an exposure to loss, and such amounts could be material.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Stockholders' Equity	STOCKHOLDERS' EQUITY Share Repurchase Program On April 26, 2023, our board of directors approved a share repurchase program with authorization to purchase up to $95 million of our common stock, excluding commissions and fees (the “Repurchase Program”). We may repurchase shares of common stock from time to time through open market purchases, in privately negotiated transactions, or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, in accordance with applicable securities laws and other restrictions. The Repurchase Program may be suspended or discontinued at any time and does not obligate us to acquire any amount of common stock.

Employee Benefit Plans

Employee Benefit Plans	9 Months Ended
	Sep. 30, 2023
Retirement Benefits [Abstract]
Employee Benefit Plans	EMPLOYEE BENEFIT PLANS Stock Incentive Plans Our 2021 Stock Incentive Plan (the “2021 Plan”) provides for the granting of incentive and non-statutory stock options, RSUs, and other equity-based awards. Pursuant to our 2021 Employee Stock Purchase Plan (the “ESPP”), eligible employees may purchase shares of our common stock through payroll deductions at 85% percent of the lower of the market price of our common stock on the date of commencement of the applicable offering period or on the last day of each six-month purchase period. As of September 30, 2023, 11,841,834 shares and 4,571,095 shares of our common stock were reserved for future issuance under the 2021 Plan and ESPP. Stock Options We may grant stock options at prices not less than the grant date fair value. These stock options generally expire 10 years from the grant date. Incentive stock options and non-statutory stock options generally vest ratably over a four-year service period. Stock option activity for the nine months ended September 30, 2023 was as follows: Number of Weighted- Weighted- Aggregate Balance—December 31, 2022 18,153,195 $ 6.07 5.41 $ 120,289 Granted 454,626 14.72 Exercised (4,926,957) 4.24 Canceled (718,104) 11.91 Balance—September 30, 2023 12,962,760 $ 6.74 5.23 $ 160,706 Options vested 10,605,948 $ 5.19 4.65 $ 145,858 The aggregate intrinsic value of options exercised was $45,941 for the nine months ended September 30, 2023. RSUs RSUs granted have a service-based vesting condition, which are satisfied generally either (i) over four years with a 25% cliff vesting period after one year and 6.25% vesting each quarter thereafter for new hires, or (ii) over four years with 6.25% vesting each quarter for new grants to existing employees. The related stock-based compensation expense is recognized on a straight-line basis over the requisite service period. RSU activity for the nine months ended September 30, 2023 was as follows: Number of Weighted-Average Aggregate Unvested balance—December 31, 2022 22,773,053 $ 17.75 $ 269,779 Granted 6,809,447 11.93 Vested (6,558,634) 18.04 Forfeited (2,898,728) 19.99 Unvested balance—September 30, 2023 20,125,138 $ 15.36 $ 376,139 Stock-Based Compensation Expense Stock-based compensation expense is classified in the Condensed Consolidated Statements of Operations (Unaudited) as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Cost of revenue $ 239 $ 683 $ 2,030 $ 2,072 Research and development 11,595 11,675 38,363 34,037 Sales and marketing 7,479 7,630 23,335 21,952 General and administrative 8,540 6,382 23,780 17,792 Restructuring related charges — — (5,605) — Total $ 27,853 $ 26,370 $ 81,903 $ 75,853 We capitalized $1,719 and $1,256 of stock-based compensation related to the development of our internal-use software during the three months ended September 30, 2023 and 2022 and $5,324 and $4,486 during the nine months ended September 30, 2023 and 2022. As of September 30, 2023, there was a total of $18,639 unrecognized employee compensation cost related to unvested stock options, which is expected to be recognized over a weighted-average period of approximately 2.0 years. In addition, as of September 30, 2023, total unrecognized compensation cost related to unvested RSUs was $254,070, which is expected to be recognized over a weighted-average period of approximately 2.7 years. Total unrecognized compensation cost related to ESPP Rights as of September 30, 2023 was $7,419, which is expected to be recognized over a weighted-average period of approximately 1.0 year. Common Stock Reserved for Issuance The following table presents total shares of our common stock reserved for future issuance: September 30, 2023 December 31, 2022 Stock options outstanding 12,962,760 18,153,195 RSUs outstanding 20,125,138 22,773,053 Shares available for future grants 16,412,929 8,819,998 Total shares of common stock reserved 49,500,827 49,746,246 401(k) Plan We have a 401(k) savings plan that provides for a discretionary employer-matching contribution. We made matching contributions of $179 and $395 to the plan for the three months ended September 30, 2023 and 2022 and $1,640 and $1,749 for the nine months ended September 30, 2023 and 2022.

Related-Party Transaction

Related-Party Transaction	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Related-Party Transaction	RELATED-PARTY TRANSACTION During the year ended December 31, 2017, we entered into a content sourcing agreement with a related party in the normal course of business and under standard terms. Content fees earned by the related party during the three months ended September 30, 2023 and 2022 were $1,974 and $1,280. Content fees earned by the related party during the nine months ended September 30, 2023 and 2022 were $5,479 and $4,456. Content fees earned by the related party were recorded within cost of revenue in the Condensed Consolidated Statements of Operations (Unaudited). As of September 30, 2023 and December 31, 2022, outstanding educator partner payables related to this content sourcing agreement were $1,974 and $1,223.

Segment and Geographic Informat

Segment and Geographic Information	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Segment and Geographic Information	SEGMENT AND GEOGRAPHIC INFORMATION Segment Information Our chief operating decision maker (“CODM”) is our Chief Executive Officer. For the purposes of allocating resources and assessing performance, the CODM examines three segments, which relate to our three revenue sources: Consumer, Enterprise, and Degrees. This is also consistent with how we disaggregate revenue. The tables below summarize the financial information for each reportable segment: Three Months Ended September 30, Nine Months Ended September 30, Revenue 2023 2022 2023 2022 Consumer $ 98,973 $ 78,002 $ 268,001 $ 215,786 Enterprise 54,887 48,044 161,240 130,794 Degrees 11,680 10,343 37,643 34,996 Total revenue $ 165,540 $ 136,389 $ 466,884 $ 381,576 Segment gross profit Consumer $ 51,762 $ 57,078 $ 141,496 $ 156,090 Enterprise 37,099 33,993 110,745 93,059 Degrees 11,680 10,343 37,643 34,996 Total segment gross profit $ 100,541 $ 101,414 $ 289,884 $ 284,145 Reconciliation of segment gross profit to gross profit Platform and support costs $ 11,973 $ 8,962 $ 32,722 $ 27,125 Stock-based compensation expense 239 683 2,030 2,072 Amortization of internal-use software 4,320 3,545 12,584 9,415 Amortization of intangible assets 736 656 2,106 1,929 Total reconciling items 17,268 13,846 49,442 40,541 Gross profit $ 83,273 $ 87,568 $ 240,442 $ 243,604 Geographic Information Revenue The following table summarizes the revenue by region based on the billing address of our customers: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 United States $ 89,018 $ 72,466 $ 249,240 $ 201,250 Europe, Middle East, and Africa 38,813 33,004 113,478 94,593 Asia Pacific 21,867 18,290 60,206 50,591 Other 15,842 12,629 43,960 35,142 Total $ 165,540 $ 136,389 $ 466,884 $ 381,576 No single country other than the United States represented 10% or more of our total revenue during the three and nine months ended September 30, 2023 and 2022. Long-lived assets The following table presents our long-lived assets, consisting of property, equipment, and software, net of depreciation and amortization, and operating lease right-of-use assets, by geographic region: September 30, 2023 December 31, 2022 United States $ 34,384 $ 35,457 Rest of World 1,290 1,244 Total $ 35,674 $ 36,701

Restructuring Related Charges

Restructuring Related Charges	9 Months Ended
	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring Related Charges	RESTRUCTURING RELATED CHARGESWe have been focusing our effort and prioritizing investments in key initiatives that are expected to drive long-term, sustainable growth. In connection with this effort, on November 9, 2022, we enacted a plan to reduce our global workforce to better align our cost structure and personnel needs with our business objectives, growth opportunities, and operational priorities.As a result of this reduction, we recognized restructuring related charges, within operating expenses, mainly related to personnel expenses, such as employee severance and benefits costs, during the year ended December 31, 2022. Related cash payments made in the three and nine months ended September 30, 2023 were $0 and $5.1 million, and reflected as cash used in operating activities within our Condensed Consolidated Statements of Cash Flows (Unaudited). We recognized a reversal of stock-based compensation expense of approximately $5.6 million during the nine months ended September 30, 2023, resulting from the forfeiture of RSUs and stock options. No restructuring related charges were recorded during the three months ended September 30, 2023. All expenses relating to this restructuring were paid as of September 30, 2023.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net loss	$ (32,090)	$ (36,038)	$ (96,197)	$ (123,640)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Sep. 30, 2023 shares	Sep. 30, 2023 shares
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Shravan K. Goli [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Shravan K. Goli, Senior Vice President and Chief Operating Officer, entered into a prearranged stock trading plan on August 28, 2023. This plan provides for the potential exercise of vested stock options and the associated sale of up to 350,022 shares of our common stock, the potential sale of vested restricted stock units of up to 215,645 shares, and the potential sale of a to-be-determined number of shares purchased under our Employee Stock Purchase Plan between November 27, 2023, and August 23, 2024.
Name	Shravan K. Goli
Title	Senior Vice President and Chief Operating Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 28, 2023
Arrangement Duration	270 days
Michele M. Meyers [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Michele M. Meyers, Vice President, Accounting and Chief Accounting Officer, entered into a prearranged stock trading plan on August 28, 2023. This plan provides for the potential sale of vested restricted stock units of up to 16,580 shares between November 27, 2023, and May 20, 2024.
Name	Michele M. Meyers
Title	Vice President, Accounting and Chief Accounting Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 28, 2023
Arrangement Duration	175 days
Aggregate Available	16,580	16,580
Shravan Goli Rule Trading Arrangement, Common Stock [Member] | Shravan K. Goli [Member]
Trading Arrangements, by Individual
Aggregate Available	350,022	350,022
Shravan Goli Trading Arrangement, Restricted Stock Units [Member] | Shravan K. Goli [Member]
Trading Arrangements, by Individual
Aggregate Available	215,645	215,645

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying Condensed Consolidated Financial Statements (Unaudited) of Coursera, Inc., a Delaware public benefit corporation, and its subsidiaries (“Coursera,” the “Company,” “we,” “us,” or “our”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and following the requirements of the Securities and Exchange Commission (“SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP can be condensed or omitted. These Condensed Consolidated Financial Statements (Unaudited) have been prepared on the same basis as our annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for a fair statement of our financial information. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other interim period or for any other future year. The balance sheet as of December 31, 2022 has been derived from the Consolidated Financial Statements at that date but does not include all information required by GAAP for annual consolidated financial statements. These Condensed Consolidated Financial Statements (Unaudited) should be read in conjunction with the Consolidated Financial Statements contained in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 23, 2023 (“Form 10-K”).
Principles of Consolidation	Principles of ConsolidationThe Condensed Consolidated Financial Statements (Unaudited) include the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Reporting Segments	Reporting Segments We conduct our operations through three reporting segments: Consumer, Enterprise, and Degrees. Refer to Note 13 for additional information.
Use of Estimates	Use of Estimates The preparation of the Condensed Consolidated Financial Statements (Unaudited) in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and related disclosures as of the date of the Condensed Consolidated Financial Statements (Unaudited), as well as the reported amounts of revenue and expenses during the reporting period. We base our estimates on historical experience, current conditions, and various other factors that we believe to be reasonable under the circumstances. Significant items subject to such estimates, judgements, and assumptions include, but are not limited to, those related to the determination of principal versus agent and variable consideration in our revenue contracts; stock-based compensation expense; period of benefit for capitalized commissions; internal-use software costs; useful lives of long-lived assets; the carrying value of operating lease right-of-use assets; the valuation of intangible assets and income tax expense, including the valuation of deferred tax assets and liabilities, among others. Actual results could differ from those estimates, and any such differences could be material to our Condensed Consolidated Financial Statements (Unaudited).
Contract Acquisition and Fulfillment Costs	Contract Acquisition and Fulfillment Costs Deferred Commissions Customer acquisition costs are primarily related to sales commissions and related payroll taxes earned by our Enterprise sales force, which are incremental costs we incur to obtain a contract. Sales commissions and related payroll costs earned by our Enterprise sales force, which are incremental costs we incur to obtain a contract, are deferred and then amortized on a straight-line basis over the expected period of benefit. On an annual basis, we assess the expected period of benefit by taking into consideration the length of terms in Enterprise customer contracts, the life of the technology, and other factors. Based on our most recent assessment, we determined that the expected period of benefit for incremental costs of our Enterprise customer contracts should be increased from three years to four years. This change in accounting estimate was eff ective January 1, 2023 and is accounted for prospectively in our Condensed Consolidated Financial Statements (Unaudited). For the three and nine months ended September 30, 2023, the change in the expected period of benefit resulted in a benefit to sales and marketing expenses o f $802 and $2,956 . Sal es commissions and related payroll taxes paid for Enterprise contract renewals continue to be amortized over the renewal term, which is generally two years. Deferred commissions and related payroll taxes are recorded within deferred costs or other assets in the consolidated balance sheets, depending on the timing of the related amortization. They are amortized to sales and marketing in the consolidated statements of operations.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject us to concentration of credit risk consist of cash, cash equivalents, and marketable securities. We only invest in high-credit-quality instruments and maintain our cash equivalents and marketable securities in fixed-income securities. We place our cash primarily with domestic financial institutions that are federally insured within statutory limits.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Contract Assets and Liabilities	Contract assets and liabilities were as follows: September 30, 2023 December 31, 2022 January 1, 2022 Contract assets: Billed accounts receivable, net of allowance for credit losses $ 55,647 $ 45,337 $ 22,286 Unbilled accounts receivable 6,457 8,397 12,110 Total contract assets $ 62,104 $ 53,734 $ 34,396 Contract liabilities: Deferred revenue $ 141,227 $ 118,777 $ 98,488 Total contract liabilities $ 141,227 $ 118,777 $ 98,488
Schedule of Capitalized Contract Cost	The following table presents our capitalization and amortization of commissions and related payroll tax expenditures: Three Months Ended September 30, Nine Months Ended September 30, Commissions and related payroll tax expenditures: 2023 2022 2023 2022 Capitalization $ 3,856 $ 4,365 $ 11,554 $ 11,464 Amortization $ 3,189 $ 3,304 $ 8,803 $ 9,051
Schedule of Deferred Costs, Net and Other Assets Disclosure	Deferred commissions and related payroll tax expenditures included in deferred costs, net and in other assets were as follows: September 30, 2023 December 31, 2022 Deferred costs, net $ 12,219 $ 13,300 Other assets $ 14,258 $ 10,426

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Summary of Available-for-Sale Marketable Securities	The following table summarizes our investments measured at fair value on a recurring basis by balance sheet classification and investment type: September 30, 2023 December 31, 2022 Amortized Gross Gross Fair Amortized Gross Gross Fair Cash equivalents—money market funds $ 204,011 $ — $ — $ 204,011 $ 304,750 $ — $ — $ 304,750 Cash equivalents—U.S. Treasury securities 271,695 40 — 271,735 — — — — Total cash equivalents 475,706 40 — 475,746 304,750 — — 304,750 Marketable securities—U.S. Treasury securities 214,255 1 (260) 213,996 460,372 26 (744) 459,654 Total $ 689,961 $ 41 $ (260) $ 689,742 $ 765,122 $ 26 $ (744) $ 764,404
Schedule of Cost Basis and Fair Value of Available-for-sale Marketable Securities by Contractual Maturity Date	The following table presents the cost basis and fair value of our available-for-sale (“AFS”) marketable securities by contractual maturity date: September 30, 2023 December 31, 2022 Amortized Fair Amortized Fair Due in one year or less $ 214,255 $ 213,996 $ 460,372 $ 459,654
Schedule of Investments in an Unrealized Loss Position	Investments in an unrealized loss position consisted of the following: September 30, 2023 December 31, 2022 Fair Gross Fair Gross U.S. Treasury securities $ 204,001 $ (260) $ 356,767 $ (744)

Consolidated Balance Sheet Co_2

Consolidated Balance Sheet Components (Tables)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Property, Equipment and Software, Net	Property, equipment, and software, net consisted of the following: September 30, 2023 December 31, 2022 Internal-use software and website development $ 68,746 $ 53,215 Computer equipment and purchased software 5,310 4,662 Leasehold improvements 6,923 6,567 Furniture and fixtures 2,759 2,714 Total property, equipment, and software 83,738 67,158 Less accumulated depreciation and amortization (54,039) (40,062) Property, equipment, and software, net $ 29,699 $ 27,096
Schedule of Depreciation and Amortization Expense	The following table presents depreciation and amortization expense related to property, equipment, and software as well as the portion of amortization expense related to internal-use software and website development that is recorded within cost of revenue in the Condensed Consolidated Statements of Operations (Unaudited): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Depreciation and amortization expense $ 4,924 $ 4,223 $ 14,396 $ 11,541 Amortization expense for internal-use software and website development $ 4,320 $ 3,545 $ 12,584 $ 9,415
Schedule of Intangible Assets, Net	Intangible assets, net consisted of the following: September 30, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Content assets $ 11,064 $ (3,025) $ 8,039 $ 6,821 $ (1,971) $ 4,850 Developed technology 8,446 (5,795) 2,651 8,446 (4,743) 3,703 Assembled workforce — — — 181 (181) — Intangible assets $ 19,510 $ (8,820) $ 10,690 $ 15,448 $ (6,895) $ 8,553
Schedule of Capitalization of Content Assets and Amortization Expense for Intangible Assets	Capitalization of content assets and amortization expense for intangible assets was as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Capitalization of content assets $ 2,247 $ 484 $ 4,243 $ 861 Amortization expense for intangible assets $ 736 $ 664 $ 2,106 $ 1,967
Schedule of Future Expected Amortization Expense for Intangible Assets	As of September 30, 2023, future expected amortization expense for intangible assets was as follows: Remainder of 2023 $ 877 2024 3,801 2025 3,214 2026 1,306 2027 875 Thereafter 617 Total $ 10,690

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss $ (32,090) $ (36,038) $ (96,197) $ (123,640) Denominator: Weighted-average shares used in computing net loss per share—basic and diluted 150,853,611 146,020,571 150,036,927 144,619,748 Net loss per share—basic and diluted $ (0.21) $ (0.25) $ (0.64) $ (0.85)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been anti-dilutive: Three and Nine Months Ended September 30, 2023 2022 Common stock options 12,962,760 18,815,019 Restricted stock units (“RSUs”) 20,125,138 19,522,108 Shares subject to repurchase 6,711 5,518 ESPP stock purchase rights (“ESPP Rights”) 335,440 287,284 Total 33,430,049 38,629,929

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	9 Months Ended
	Sep. 30, 2023
Retirement Benefits [Abstract]
Schedule of Stock Option Activity	Stock option activity for the nine months ended September 30, 2023 was as follows: Number of Weighted- Weighted- Aggregate Balance—December 31, 2022 18,153,195 $ 6.07 5.41 $ 120,289 Granted 454,626 14.72 Exercised (4,926,957) 4.24 Canceled (718,104) 11.91 Balance—September 30, 2023 12,962,760 $ 6.74 5.23 $ 160,706 Options vested 10,605,948 $ 5.19 4.65 $ 145,858
Schedule of Share-based Compensation, Restricted Stock Units Award Activity	RSU activity for the nine months ended September 30, 2023 was as follows: Number of Weighted-Average Aggregate Unvested balance—December 31, 2022 22,773,053 $ 17.75 $ 269,779 Granted 6,809,447 11.93 Vested (6,558,634) 18.04 Forfeited (2,898,728) 19.99 Unvested balance—September 30, 2023 20,125,138 $ 15.36 $ 376,139
Schedule of Stock-Based Compensation Expense in the Consolidated Statements of Operations	Stock-based compensation expense is classified in the Condensed Consolidated Statements of Operations (Unaudited) as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Cost of revenue $ 239 $ 683 $ 2,030 $ 2,072 Research and development 11,595 11,675 38,363 34,037 Sales and marketing 7,479 7,630 23,335 21,952 General and administrative 8,540 6,382 23,780 17,792 Restructuring related charges — — (5,605) — Total $ 27,853 $ 26,370 $ 81,903 $ 75,853
Schedule of Shares of Common Stock Reserved for Future Issuance	The following table presents total shares of our common stock reserved for future issuance: September 30, 2023 December 31, 2022 Stock options outstanding 12,962,760 18,153,195 RSUs outstanding 20,125,138 22,773,053 Shares available for future grants 16,412,929 8,819,998 Total shares of common stock reserved 49,500,827 49,746,246

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Schedule of Financial Information for Each Reportable Segment	The tables below summarize the financial information for each reportable segment: Three Months Ended September 30, Nine Months Ended September 30, Revenue 2023 2022 2023 2022 Consumer $ 98,973 $ 78,002 $ 268,001 $ 215,786 Enterprise 54,887 48,044 161,240 130,794 Degrees 11,680 10,343 37,643 34,996 Total revenue $ 165,540 $ 136,389 $ 466,884 $ 381,576 Segment gross profit Consumer $ 51,762 $ 57,078 $ 141,496 $ 156,090 Enterprise 37,099 33,993 110,745 93,059 Degrees 11,680 10,343 37,643 34,996 Total segment gross profit $ 100,541 $ 101,414 $ 289,884 $ 284,145 Reconciliation of segment gross profit to gross profit Platform and support costs $ 11,973 $ 8,962 $ 32,722 $ 27,125 Stock-based compensation expense 239 683 2,030 2,072 Amortization of internal-use software 4,320 3,545 12,584 9,415 Amortization of intangible assets 736 656 2,106 1,929 Total reconciling items 17,268 13,846 49,442 40,541 Gross profit $ 83,273 $ 87,568 $ 240,442 $ 243,604
Schedule of Revenue by Region Based on Billing Address	The following table summarizes the revenue by region based on the billing address of our customers: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 United States $ 89,018 $ 72,466 $ 249,240 $ 201,250 Europe, Middle East, and Africa 38,813 33,004 113,478 94,593 Asia Pacific 21,867 18,290 60,206 50,591 Other 15,842 12,629 43,960 35,142 Total $ 165,540 $ 136,389 $ 466,884 $ 381,576
Schedule of Long-lived Assets by Geographic Region	The following table presents our long-lived assets, consisting of property, equipment, and software, net of depreciation and amortization, and operating lease right-of-use assets, by geographic region: September 30, 2023 December 31, 2022 United States $ 34,384 $ 35,457 Rest of World 1,290 1,244 Total $ 35,674 $ 36,701

Significant Accounting Polici_3

Significant Accounting Policies (Details) $ in Thousands			3 Months Ended		9 Months Ended
	Jan. 01, 2023	Dec. 31, 2022	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) segment	Sep. 30, 2022 USD ($)
Change in Accounting Estimate [Line Items]
Number of operating segments | segment					3
Contract with customer expected incremental cost period	4 years	3 years
Sales and marketing			$ 59,792	$ 58,504	$ 164,665	$ 165,757
Contract with customer amortization on renewal period					2 years
Change in Accounting Method Accounted for as Change in Estimate
Change in Accounting Estimate [Line Items]
Sales and marketing			$ 802		$ 2,956

Revenue Recognition - Schedule

Revenue Recognition - Schedule of Contract Assets and Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Contract assets:
Billed accounts receivable, net of allowance for credit losses	$ 55,647	$ 45,337	$ 22,286
Unbilled accounts receivable	6,457	8,397	12,110
Total contract assets	62,104	53,734	34,396
Contract liabilities:
Deferred revenue	141,227	118,777	98,488
Total contract liabilities	$ 141,227	$ 118,777	$ 98,488

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue Recognized			$ 107,448	$ 85,754
Russian Educator Partners
Disaggregation of Revenue [Line Items]
Impairment losses on deferred partner fees	$ 1,473	$ 1,029	2,008	$ 2,915
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation	$ 318,806		$ 318,806
Percent of remaining performance obligations to be recognized	66%		66%
Period for satisfaction of remaining performance obligation	12 months		12 months

Revenue Recognition - Schedul_2

Revenue Recognition - Schedule of Capitalized Contract Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Capitalization	$ 3,856	$ 4,365	$ 11,554	$ 11,464
Amortization	$ 3,189	$ 3,304	$ 8,803	$ 9,051

Revenue Recognition - Schedul_3

Revenue Recognition - Schedule of Deferred Costs, Net and Other Assets Disclosure (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred costs, net	$ 12,219	$ 13,300
Other assets	$ 14,258	$ 10,426

Investments - Summary of Availa

Investments - Summary of Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	$ 689,961	$ 765,122
Gross Unrealized Gains	41	26
Gross Unrealized Losses	(260)	(744)
Fair Value - Level 1	689,742	764,404
Marketable securities—U.S. Treasury securities
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	214,255	460,372
Gross Unrealized Gains	1	26
Gross Unrealized Losses	(260)	(744)
Fair Value - Level 1	213,996	459,654
Cash and Cash Equivalents
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	475,706	304,750
Gross Unrealized Gains	40	0
Gross Unrealized Losses	0	0
Fair Value - Level 1	475,746	304,750
Cash and Cash Equivalents | Cash equivalents—money market funds
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	204,011	304,750
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value - Level 1	204,011	304,750
Cash and Cash Equivalents | Marketable securities—U.S. Treasury securities
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	271,695	0
Gross Unrealized Gains	40	0
Gross Unrealized Losses	0	0
Fair Value - Level 1	$ 271,735	$ 0

Investments - Schedule of Cost

Investments - Schedule of Cost Basis and Fair Value of Available-for-sale Marketable Securities by Contractual Maturity Date (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Amortized Cost	$ 214,255	$ 460,372
Fair Value	$ 213,996	$ 459,654

Investments - Schedule of Inves

Investments - Schedule of Investments in an Unrealized Loss Position (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Schedule Of Available For Sale Securities [Line Items]
Gross Unrealized Losses	$ (260)	$ (744)
U.S. Treasury securities
Schedule Of Available For Sale Securities [Line Items]
Fair Value	204,001	356,767
Gross Unrealized Losses	$ (260)	$ (744)

Investments - Additional Inform

Investments - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Aug. 31, 2023
Schedule of Equity Method Investments [Line Items]
Credit or non credit impairment charges	$ 0	$ 0	$ 0	$ 0
Private Company
Schedule of Equity Method Investments [Line Items]
Ownership interest in equity method investment, percentage					7%
Carrying value of investment	$ 1,701,000		$ 1,701,000

Consolidated Balance Sheet Co_3

Consolidated Balance Sheet Components - Schedule of Property, Equipment and Software, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property Plant And Equipment [Line Items]
Total property, equipment, and software	$ 83,738	$ 67,158
Less accumulated depreciation and amortization	(54,039)	(40,062)
Property, equipment, and software, net	29,699	27,096
Internal-use software and website development
Property Plant And Equipment [Line Items]
Total property, equipment, and software	68,746	53,215
Computer equipment and purchased software
Property Plant And Equipment [Line Items]
Total property, equipment, and software	5,310	4,662
Leasehold improvements
Property Plant And Equipment [Line Items]
Total property, equipment, and software	6,923	6,567
Furniture and fixtures
Property Plant And Equipment [Line Items]
Total property, equipment, and software	$ 2,759	$ 2,714

Consolidated Balance Sheet Co_4

Consolidated Balance Sheet Components - Schedule of Depreciation and Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Property Plant And Equipment [Line Items]
Depreciation and amortization expense			$ 16,502	$ 13,507
Amortization expense for internal-use software and website development	$ 736	$ 664	2,106	1,967
Property, Equipment and Software
Property Plant And Equipment [Line Items]
Depreciation and amortization expense	4,924	4,223	14,396	11,541
Software and Website Development
Property Plant And Equipment [Line Items]
Amortization expense for internal-use software and website development	$ 4,320	$ 3,545	$ 12,584	$ 9,415

Consolidated Balance Sheet Co_5

Consolidated Balance Sheet Components - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Finite Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 19,510	$ 15,448
Accumulated Amortization	(8,820)	(6,895)
Net Carrying Value	10,690	8,553
Content assets
Finite Lived Intangible Assets [Line Items]
Gross Carrying Value	11,064	6,821
Accumulated Amortization	(3,025)	(1,971)
Net Carrying Value	8,039	4,850
Developed technology
Finite Lived Intangible Assets [Line Items]
Gross Carrying Value	8,446	8,446
Accumulated Amortization	(5,795)	(4,743)
Net Carrying Value	2,651	3,703
Assembled workforce
Finite Lived Intangible Assets [Line Items]
Gross Carrying Value	0	181
Accumulated Amortization	0	(181)
Net Carrying Value	$ 0	$ 0

Consolidated Balance Sheet Co_6

Consolidated Balance Sheet Components - Schedule of Capitalization of Content Assets and Amortization Expense for Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Finite Lived Intangible Assets [Line Items]
Amortization expense for intangible assets	$ 736	$ 664	$ 2,106	$ 1,967
Content assets
Finite Lived Intangible Assets [Line Items]
Capitalization of content assets	$ 2,247	$ 484	$ 4,243	$ 861

Consolidated Balance Sheet Co_7

Consolidated Balance Sheet Components - Schedule of Future Expected Amortization Expense for Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Remainder of 2023	$ 877
2024	3,801
2025	3,214
2026	1,306
2027	875
Thereafter	617
Net Carrying Value	$ 10,690	$ 8,553

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Sublease income	$ 680	$ 680	$ 2,040	$ 907
Property and equipment		0		904
Impairment Loss	$ 0	$ 0	$ 0	$ 2,304

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Effective tax rate	3.30%	2.90%	4.40%	2.60%

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Numerator:
Net loss	$ (32,090)	$ (36,038)	$ (96,197)	$ (123,640)
Denominator:
Weighted-average shares used in computing net loss per share - basic (in shares)	150,853,611	146,020,571	150,036,927	144,619,748
Weighted-average shares used in computing net loss per share - diluted (in shares)	150,853,611	146,020,571	150,036,927	144,619,748
Net loss per share - basic (in dollars per share)	$ (0.21)	$ (0.25)	$ (0.64)	$ (0.85)
Net loss per share - diluted (in dollars per share)	$ (0.21)	$ (0.25)	$ (0.64)	$ (0.85)

Net Loss Per Share - Schedule_2

Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of dilutive earnings per share (in shares)	33,430,049	38,629,929	33,430,049	38,629,929
Common stock options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of dilutive earnings per share (in shares)	12,962,760	18,815,019	12,962,760	18,815,019
Restricted stock units (“RSUs”)
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of dilutive earnings per share (in shares)	20,125,138	19,522,108	20,125,138	19,522,108
Shares subject to repurchase
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of dilutive earnings per share (in shares)	6,711	5,518	6,711	5,518
ESPP stock purchase rights (“ESPP Rights”)
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of dilutive earnings per share (in shares)	335,440	287,284	335,440	287,284

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Thousands	Sep. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Non-cancelable purchase obligations	$ 24,934

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Apr. 26, 2023
Equity [Abstract]
Stock repurchase program authorized amount			$ 95
Number of shares, repurchased (in shares)	309,510	4,829,803
Stock repurchased, value	$ 3.9	$ 58.5
Stock repurchase program, remaining authorized repurchase amount	$ 36.6	$ 36.6

Employee Benefit Plans - Additi

Employee Benefit Plans - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total shares of common stock reserved (in shares)	49,500,827		49,500,827		49,746,246
Aggregate intrinsic value of employee options exercised			$ 45,941
Compensation cost related to the nonvested awards not yet recognized	$ 18,639		$ 18,639
Weighted average period for recognition of compensation cost			2 years
Employer discretionary contribution amount	179	$ 395	$ 1,640	$ 1,749
Internal-use software and website development
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
cumulative stock-based compensation expense	$ 1,719	$ 1,256	$ 5,324	$ 4,486
Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percent of the lower of the market price for Purchase shares of common stock			85%
Employee stock incentive plan purchase period			6 months
Total shares of common stock reserved (in shares)	4,571,095		4,571,095
Compensation cost related to the nonvested awards not yet recognized	$ 7,419		$ 7,419
Weighted average period for recognition of compensation cost			1 year
2021 Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total shares of common stock reserved (in shares)	11,841,834		11,841,834
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation, expiration period			10 years
Vesting period			4 years
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period			4 years
Compensation cost related to the nonvested awards not yet recognized	$ 254,070		$ 254,070
Weighted average period for recognition of compensation cost			2 years 8 months 12 days
Restricted Stock Units | Share-Based Payment Arrangement, Tranche One
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award vesting rights percentage			25%
Cliff vesting period			1 year
Restricted Stock Units | Share-Based Payment Arrangement, Tranche Two
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award vesting rights percentage			6.25%
Restricted Stock Units | Share-Based Payment Arrangement, Tranche Three
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award vesting rights percentage			6.25%

Employee Benefit Plans - Schedu

Employee Benefit Plans - Schedule of Stock Option Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares
Number of Shares
Number of shares, beginning balance (in shares)	18,153,195
Number of shares, ending balance (in shares)	12,962,760	18,153,195
Stock Options
Number of Shares
Number of shares, beginning balance (in shares)	18,153,195
Number of shares, granted (in shares)	454,626
Number of shares, exercised (in shares)	(4,926,957)
Number of shares, canceled (in shares)	(718,104)
Number of shares, ending balance (in shares)	12,962,760	18,153,195
Number of shares, options vested (in shares)	10,605,948
Weighted- Average Exercise Price
Weighted-average exercise price, beginning balance (in dollars per share) | $ / shares	$ 6.07
Weighted-average exercise price, granted (in dollars per share) | $ / shares	14.72
Weighted-average exercise price, exercised (in dollars per share) | $ / shares	4.24
Weighted-average exercise price, canceled (in dollars per share) | $ / shares	11.91
Weighted-average exercise price, ending balance (in dollars per share) | $ / shares	6.74	$ 6.07
Weighted-average exercise price, options vested (in dollars per share) | $ / shares	$ 5.19
Weighted-average remaining contractual term, balance	5 years 2 months 23 days	5 years 4 months 28 days
Weighted-average remaining contractual term, options vested	4 years 7 months 24 days
Aggregate intrinsic value | $	$ 160,706	$ 120,289
Aggregate intrinsic value, options vested | $	$ 145,858

Employee Benefit Plans - Sche_2

Employee Benefit Plans - Schedule of Share-based Compensation, Restricted Stock Units Award Activity (Details) - Restricted Stock Units - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Number of Shares
Number of shares, unvested beginning balance (in shares)	22,773,053
Number of shares, granted (in shares)	6,809,447
Number of shares, vested (in shares)	(6,558,634)
Number of shares, forfeited (in shares)	(2,898,728)
Number of shares, unvested ending balance (in shares)	20,125,138
Weighted-Average Grant Date Fair Value
Weighted-average grant date fair value, unvested beginning balance (in dollars per share)	$ 17.75
Weighted-average grant date fair value, granted (in dollars per share)	11.93
Weighted-average grant date fair value, vested (in dollars per share)	18.04
Weighted-average grant date fair value, forfeited (in dollars per share)	19.99
Weighted-average grant date fair value, unvested ending balance (in dollars per share)	$ 15.36
Aggregate intrinsic value, unvested balance	$ 376,139	$ 269,779

Employee Benefit Plans - Sche_3

Employee Benefit Plans - Schedule of Stock-Based Compensation Expense in the Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total	$ 27,853	$ 26,370	$ 81,903	$ 75,853
Cost of revenue
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total	239	683	2,030	2,072
Research and development
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total	11,595	11,675	38,363	34,037
Sales and marketing
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total	7,479	7,630	23,335	21,952
General and administrative
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total	8,540	6,382	23,780	17,792
Restructuring related charges
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total	$ 0	$ 0	$ (5,605)	$ 0

Employee Benefit Plans - Sche_4

Employee Benefit Plans - Schedule of Shares of Common Stock Reserved for Future Issuance (Details) - shares	Sep. 30, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Stock options outstanding (in shares)	12,962,760	18,153,195
RSUs outstanding (in shares)	20,125,138	22,773,053
Shares available for future grants (in shares)	16,412,929	8,819,998
Total shares of common stock reserved	49,500,827	49,746,246

Related-Party Transaction (Deta

Related-Party Transaction (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Educator partners payable	$ 98,063		$ 98,063		$ 66,375
Content Sourcing Agreement | Related Party
Related Party Transaction [Line Items]
Related party content fees	1,974	$ 1,280	5,479	$ 4,456
Educator partners payable	$ 1,974		$ 1,974		$ 1,223

Segment and Geographic Inform_3

Segment and Geographic Information - Additional Information (Details)	9 Months Ended
	Sep. 30, 2023 segment
Segment Reporting [Abstract]
Number of segments	3

Segment and Geographic Inform_4

Segment and Geographic Information - Schedule of Financial Information for Each Reportable Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue
Total revenue	$ 165,540	$ 136,389	$ 466,884	$ 381,576
Segment gross profit
Total segment gross profit	83,273	87,568	240,442	243,604
Amortization expense for internal-use software and website development	736	664	2,106	1,967
Total reconciling items	82,267	48,821	226,442	137,972
Operating Segments
Segment gross profit
Total segment gross profit	100,541	101,414	289,884	284,145
Segment Reconciling Items
Segment gross profit
Platform and support costs	11,973	8,962	32,722	27,125
Stock-based compensation expense	239	683	2,030	2,072
Total reconciling items	17,268	13,846	49,442	40,541
Amortization of internal-use software | Segment Reconciling Items
Segment gross profit
Amortization expense for internal-use software and website development	4,320	3,545	12,584	9,415
Amortization of intangible assets | Segment Reconciling Items
Segment gross profit
Amortization expense for internal-use software and website development	736	656	2,106	1,929
Consumer
Revenue
Total revenue	98,973	78,002	268,001	215,786
Consumer | Operating Segments
Segment gross profit
Total segment gross profit	51,762	57,078	141,496	156,090
Enterprise
Revenue
Total revenue	54,887	48,044	161,240	130,794
Enterprise | Operating Segments
Segment gross profit
Total segment gross profit	37,099	33,993	110,745	93,059
Degrees
Revenue
Total revenue	11,680	10,343	37,643	34,996
Degrees | Operating Segments
Segment gross profit
Total segment gross profit	$ 11,680	$ 10,343	$ 37,643	$ 34,996

Segment and Geographic Inform_5

Segment and Geographic Information - Schedule of Revenue by Region Based on Billing Address (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Total	$ 165,540	$ 136,389	$ 466,884	$ 381,576
United States
Segment Reporting Information [Line Items]
Total	89,018	72,466	249,240	201,250
Europe, Middle East, and Africa
Segment Reporting Information [Line Items]
Total	38,813	33,004	113,478	94,593
Asia Pacific
Segment Reporting Information [Line Items]
Total	21,867	18,290	60,206	50,591
Other
Segment Reporting Information [Line Items]
Total	$ 15,842	$ 12,629	$ 43,960	$ 35,142

Segment and Geographic Inform_6

Segment and Geographic Information - Schedule of Long-lived Assets by Geographic Region (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total	$ 35,674	$ 36,701
United States
Segment Reporting Information [Line Items]
Total	34,384	35,457
Rest of World
Segment Reporting Information [Line Items]
Total	$ 1,290	$ 1,244

Restructuring Related Charges (

Restructuring Related Charges (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]
Payments for restructuring	$ 0		$ 5,100,000
Reversal of stock-based compensation expense	27,853,000	$ 26,370,000	81,903,000	$ 75,853,000
Restructuring related charges	$ 0	$ 0	(5,806,000)	$ 0
Restricted Stock Units and Options
Restructuring Cost and Reserve [Line Items]
Reversal of stock-based compensation expense			$ 5,600,000